Enabling Data Integrity From Drug Discovery Through Manufacturing
White Paper Sep 30, 2020
When evaluating the success of a drug therapy, biopharmaceutical companies are increasingly putting data quality and data integrity at the top of their list.
High data quality and integrity is critical to ensure patient safety and drug efficacy from research and development through to manufacturing.
This whitepaper examines data integrity at every stage of the drug development process.
Download this whitepaper to discover:
- How to use ALCOA+ principles to ensure data integrity
- The regulatory guidelines that bioanalytical studies must adhere to
- How informatics solutions can help keep development processes compliant
Related White Papers
Life science R&D is developing incredible solutions to global problems. But this ground breaking work is often being done with outdated tools that weren't designed with the complexity of life science in mind. Let's explore the core questions that R&D organizations are struggling to answer.READ MORE